Machine learning drives progress in fibrosis treatment Insilico’s Phase 2a trial of an AI-designed therapy marks a milestone in data-driven drug development.

https://www.drugdiscoverynews.com/machine-learning-drives-progress-in-fibrosis-treatment-16515?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9tNMD9PiAxVORbc4q3E1Zp7wjCX65yBTkYbyosVe-Jqg0qIfZvfDRLSfJaUZNZAUWUwkUZXXPT43TN_PTZ_qQTEIs1-Q&_hsmi=372996550&utm_content=372996550&utm_source=hs_email